Vallina Carmen, López-Pintor Rosa María, González-Serrano José, de Vicente Juan Carlos, Hernández Gonzalo, Lorz Corina
School of Medicine and Dentistry, Oviedo University, Julián clavería s/n, 33006 Oviedo, Spain.
ORALMED Research Group, Department of Dental Clinical Specialties, School of Dentistry, Complutense University, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
Oral Oncol. 2021 Jun;117:105310. doi: 10.1016/j.oraloncology.2021.105310. Epub 2021 Apr 23.
Epithelial-mesenchymal transition (EMT) is considered the initial step in the invasion-metastasis cascade. The aim of this systematic review was to study the signature of genes involved in the EMT process in oral cancer (OC) confirmed by protein expression and its possible relationship with oral squamous cell carcinoma (OSCC) prognostic variables.
A search of the scientific literature was carried out with no start date restriction until 17 September 2020 in the electronic databases Pubmed/MEDLINE, Web of Science, Cochrane Library and Scopus, following specific eligibility criteria. The methodological quality of the included studies was assessed using the Newcastle-Ottawa tool.
A total of 8 retrospective cohort studies were included, all of them performed in China and with low risk of bias. Overexpression of the genes HNRNPC, ITGA5, HMGA2 and SRSF3, and low expression of ALDH3A1 and ARID2 promote EMT in OC. The more advanced clinical stages of the TNM classification were significantly associated with overexpression of HNRNPC, ITGA5, HMGA2 and SRSF3, and low expression of ARID2.
HNRNPC, ITGA5, HMGA2, SRSF3, ALDH3A1 and ARID2 genes were associated with EMT process. Over- or under-expression of these genes is associated with worse stages of OSCC and/or worse prognosis of the tumor. Further studies on this topic are needed in different countries to be able to confirm these results, since the detection of these genes can help to know which tumors have a worse prognosis.
上皮-间质转化(EMT)被认为是侵袭-转移级联反应的起始步骤。本系统评价的目的是研究经蛋白表达证实的口腔癌(OC)中参与EMT过程的基因特征及其与口腔鳞状细胞癌(OSCC)预后变量的可能关系。
按照特定的纳入标准,在电子数据库PubMed/MEDLINE、科学网、考克兰图书馆和Scopus中对科学文献进行检索,检索无起始日期限制,截至2020年9月17日。使用纽卡斯尔-渥太华工具评估纳入研究的方法学质量。
共纳入8项回顾性队列研究,均在中国进行,且偏倚风险较低。基因HNRNPC、ITGA5、HMGA2和SRSF3的过表达,以及ALDH3A1和ARID2的低表达促进OC中的EMT。TNM分类中更高级别的临床分期与HNRNPC、ITGA5、HMGA2和SRSF3的过表达以及ARID2的低表达显著相关。
HNRNPC、ITGA5、HMGA2、SRSF3、ALDH3A1和ARID2基因与EMT过程相关。这些基因的过表达或低表达与OSCC的更差分期和/或肿瘤的更差预后相关。由于对这些基因的检测有助于了解哪些肿瘤预后较差,因此需要在不同国家对该主题进行进一步研究以证实这些结果。